DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

 

Ultrasound Homepage

AI drives first ejection fraction cardiac software tool for mobile ultrasound DiA Imaging Analysis platform now available with GE's Vscan handheld ultrasound

Could a Band-Aid-sized $100 ultrasound transducer be coming soon? Researchers are optimistic, as image quality matches or exceeds conventional systems

Philips to manage medical imaging equipment for Aussie providers for 20 years First-of-its-kind partnership in Australia and ASEAN Pacific region

Purdue research groups enhancing medical imaging with optical innovations Developing optical ultrasound and 3D printed, optical phantoms

Olympus enters separate collabs on endoscopic ultrasound and 3D surgery Partners with Hitachi Healthcare Americas and FlexDex

Philips unveils new ultrasounds for general and interventional cardiology Equipped with anatomical intelligence

China hits back with new tariffs affecting medical imaging equipment More than 5,000 items affected, including X-ray tubes and gamma-ray equipment

FDA greenlights focused ultrasound trial for Alzheimer's treatment Involves temporarily opening the blood-brain barrier

Could AI and 3D printing be the future of OB/GYN ultrasound? Few specialities are equally poised to embrace these cutting edge tools

Healcerion gets FDA nod for wireless ultrasound SONON 300L is 1/10th the cost of traditional systems

Concept illustration of a cart based
ultrasound and TAEUS platform
courtesy: ENDRA

GE and ENDRA extend agreement to advance liver ultrasound

John W. Mitchell , Senior Correspondent
The increasing worldwide incidence of liver disease, driven by obesity, diabetes and hepatitis, is pushing imaging companies to develop new technology for earlier diagnosis. ENDRA has renewed an agreement with GE Healthcare to continue work on a standard CT application.

“Over one billion people are affected by fatty liver disease (NAFLD), which can progress to inflammation (NASH), then fibrosis scarring, then cirrhosis or cell death and then to cancer,” Francois Michelon, CEO at ENDRA Life Sciences told HCB News. “There are no practical tools for diagnosing NAFLD and NASH.”

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



To remedy this, EDRA has developed Thermo Acoustic Enhanced Ultrasound (TAEUS) that will enable standard ultrasound to detect such liver diseases in the early stage, while it is still reversible. Currently, the company said, ultrasound can only indicate liver diseases in the late stages.

ENDRA and GE Healthcare are working to deploy the technology in Europe by the end of 2018. Michelon said the expected cost of the unit would be about $40,000.

“We believe that ENDRA's technology has the potential to bring significant new capabilities to ultrasound - which aligns well with GE Healthcare's mission of increasing access to high-quality, cost-effective health care,” said Brian McEathron, GE Healthcare's vice president and general manager for General Imaging Ultrasound. “We're very excited about completing the final steps toward commercialization of ENDRA's TAEUS fatty liver product."

Michelon said TAUES is safer and more economical than other standard protocols. MR/CT technology, he noted, is expensive to acquire at between $1-3 million. Surgical biopsy is another alternative, but the procedure is also expensive, painful and carries the risk of complications. And blood liver enzyme level testing is unreliable he said, with about half of all NAFLD patients testing normal.

“The key benefit of ENDRA's technology is that it leverages conventional ultrasound, which is widely accepted as safe, cost-effective, easy-to-use, and broadly available. This broadens access to better health care,” said Michelon.

TAEUS will also offer more widespread diagnostic testing for liver disease, according to Michelon. Physicians will gain a new, cost-effective, and safe tool to address the growing crisis of liver disease. They will be able to deliver better health care to more people in clinics, community hospitals, private practices, patient bedsides – wherever ultrasound is used.

“By diagnosing NAFLD earlier on ultrasound, insurers will start reducing downstream costs of advanced liver disease, such as expensive inpatient care and liver transplants, as well as avoid costs of more expensive diagnostic tools such as CT and MR,” said Michelon.

ENDRA is also developing several other software applications to enhance ultrasound. This includes an application to indicate tissue temperature with ultrasound during energy-based surgeries to treat cancer and heart conditions.

Ultrasound Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有